ACRO BIOMEDICAL CO., LTD. 8-K

What Happened
ACRO BIOMEDICAL Co., Ltd. (ACBM) filed an 8-K reporting a change in its independent registered public accounting firm. The company dismissed KCCW and on January 4, 2026 its board approved the engagement of Weinberg & Company as the new independent auditor. KCCW had issued audit reports for the fiscal years ended December 31, 2024 and 2023; those reports contained no adverse or qualified opinions but included an explanatory paragraph about uncertainty as to the company’s ability to continue as a going concern.

Key Details

• Board approved Weinberg & Company as ACBM’s independent registered public accounting firm on January 4, 2026.
• KCCW issued audit reports for fiscal years ended Dec 31, 2024 and 2023 with no adverse or qualified opinion, but with a going-concern explanatory paragraph.
• The company reports no disagreements with KCCW on accounting principles, financial statement disclosure, or auditing scope for 2023–2024 and interim periods to KCCW’s dismissal.
• ACBM says it did not consult Weinberg during fiscal 2025 or the interim period about the application of accounting principles or reportable events.

Why It Matters
A change in independent auditor is material because auditors review and sign off on the company’s financial statements. The presence of a going-concern explanatory paragraph in KCCW’s prior reports signals previously disclosed uncertainty about ACBM’s ability to continue operations — a fact investors should note when assessing financial risk. The filing also states there were no unresolved disagreements with the former auditor, and the company has requested a letter from KCCW to the SEC confirming the statements in the 8-K.